- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-7265
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab ; day:23 ; month:5 ; year:2019 ; pages:1-4
Clinical journal of gastroenterology ; (23.5.2019), 1-4
- Creator
-
Carlsen, Arne
Grimstad, Tore Bjørn
Karlsen, Lars Normann
Greve, Ole Jacob
Norheim, Katrine Brække
Lea, Dordi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12328-019-00994-8
- URN
-
urn:nbn:de:101:1-2019110110032981389508
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Carlsen, Arne
- Grimstad, Tore Bjørn
- Karlsen, Lars Normann
- Greve, Ole Jacob
- Norheim, Katrine Brække
- Lea, Dordi
- SpringerLink (Online service)
Other Objects (12)
Monoclonal antibody therapy
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference
Monoclonal antibody applications in travel medicine
Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Monoclonal antibody humanness score and its applications
Dynamic optimization strategies for monoclonal antibody production
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
Quality-targeting dynamic optimization of monoclonal antibody production
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Monoclonal antibody therapy
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference
Monoclonal antibody applications in travel medicine
Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Monoclonal antibody humanness score and its applications
Dynamic optimization strategies for monoclonal antibody production
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
Quality-targeting dynamic optimization of monoclonal antibody production
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Monoclonal antibody therapy
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference
Monoclonal antibody applications in travel medicine
Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Monoclonal antibody humanness score and its applications
Dynamic optimization strategies for monoclonal antibody production
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
Quality-targeting dynamic optimization of monoclonal antibody production